Cargando…
Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected patients by synthesizing several inflammatory mediators, including cytokines that initiate intracellular signaling. Recently, small molecule inhibitors of transduction and transcription signals that influence the intracellular pathw...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890964/ https://www.ncbi.nlm.nih.gov/pubmed/24453498 http://dx.doi.org/10.2147/JIR.S35901 |